Lauren Charamut Team MMRF

Lauren joined the MMRF Endurance Events Staff in January 2018. Previously she was a participant in the 2016 TCS NYC Marathon and 2017 MM4MM Mt. Fuji hike, both with the Multiple Myeloma Research Foundation as a fundraiser and participant. Lauren’s mom is a multiple myeloma patient and is currently in remission. Lauren is proud to work on the events that once helped her support her mom and knows how meaningful her work is. “I could not think of a better way to continue to support my mother and all the myeloma patients I have come to know than working tirelessly at the organization that has fought so hard to provide the treatments that are saving my mother’s life.”

Sorry, there are no posts from this member.
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More